The DPT vaccine, also called the DTP vaccine, is a class of combination vaccines that protect against three infectious diseases: diphtheria, pertussis (whooping cough) and tetanus. Its components include diphtheria and tetanus toxoids together with either killed whole cells of the pertussis-causing bacterium or purified pertussis antigens, depicted respectively as DTwP (whole-cell) or DTaP (acellular) formulations. Because the vaccine uses inactivated toxoid rather than a live pathogen, it carries no known risk of causing the diseases themselves and is considered safe for use in immune-compromised populations. In the United States, the whole-cell DPT vaccine was administered as part of the childhood vaccination schedule recommended by the Centers for Disease Control and Prevention until 1996, when the acellular DTaP vaccine was licensed for use.
Facts
Origin YearSourced to the subject's own account Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/DPT_vaccine, lead sectionQuote, https://en.wikipedia.org/wiki/DPT_vaccine, lead section
The DPT vaccine or DTP vaccine is a class of combination vaccines to protect against three infectious diseases in humans: diphtheria, pertussis, and tetanus (lockjaw).
2. DPT vaccine (Wikipedia)
WikipediaHistory section, DTP vaccination licensed in 1949Quote, History section, DTP vaccination licensed in 1949
Diphtheria and tetanus toxoids and whole-cell pertussis (DTP; now also "DTwP" to differentiate from the broader class of triple-combination vaccines) vaccination was licensed in 1949.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.